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Abstract
Background: Diabetes-related foot disease (DFD) is a leading cause of global hospitalisation, amputation and
disability burdens; yet, the epidemiology of the DFD burden is unclear in Australia. We aimed to systematically
review the literature reporting the prevalence and incidence of risk factors for DFD (e.g. neuropathy, peripheral
artery disease), of DFD (ulcers and infection), and of diabetes-related amputation (total, minor and major
amputation) in Australian populations.
Methods: We systematically searched PubMed and EMBASE databases for peer-reviewed articles published until
December 31, 2019. We used search strings combining key terms for prevalence or incidence, DFD or amputation,
and Australia. Search results were independently screened for eligibility by two investigators. Publications that
reported prevalence or incidence of outcomes of interest in geographically defined Australian populations were
eligible for inclusion. Included studies were independently assessed for methodological quality and key data were
extracted by two investigators.
Results: Twenty publications met eligibility and were included. There was high heterogeneity for populations
investigated and methods used to identify outcomes. We found within diabetes populations, the prevalence of risk
factors ranged from 10.0–58.8%, of DFD from 1.2–1.5%, and the incidence of diabetes-related amputation ranged
from 5.2–7.2 per 1000 person-years. Additionally, the incidence of DFD-related hospitalisation ranged from 5.2–36.6
per 1000 person-years within diabetes populations. Furthermore, within inpatients with diabetes, we found the
prevalence of risk factors ranged from 35.3–43.3%, DFD from 7.0–15.1% and amputation during hospitalisation from
1.4–5.8%.
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Conclusions: Our review suggests a similar risk factor prevalence, low but uncertain DFD prevalence, and high
DFD-related hospitalisation and amputation incidence in Australia compared to international populations. These
findings may suggest that a low proportion of people with risk factors develop DFD, however, it is also possible
that there is an underestimation of DFD prevalence in Australia in the few limited studies, given the high incidence
of hospitalisation and amputation because of DFD. Either way, studies of nationally representative populations
using valid outcome measures are needed to verify these DFD-related findings and interpretations.
Keywords: Diabetic foot, Diabetes complications, Diabetic neuropathies, Peripheral arterial disease, Foot ulcer,
Amputation, Diabetes mellitus, Epidemiology
Background
Diabetes-related foot disease (DFD) is a leading cause of
hospitalisation, amputation, disability and health care
costs internationally [1–3]. DFD is typically defined as
ulceration or infection of the foot associated with the
key risk factors of peripheral neuropathy or peripheral
artery disease (PAD) in people with diabetes [4]. Global
estimates indicate approximately 130 million people
have a key risk factor for DFD, 20 million of those have
DFD [3], and up to 2 million of those require an ampu-
tation each year [1, 5].
Epidemiological research is the cornerstone of inform-
ing health care policy across the world [6]. Amputation
incidence is frequently used in this regard as a key
marker of the burden and health care quality of DFD [7,
8]. Recent large systematic reviews and meta-analyses
have reported 4.6–4.8% of the global population with
diabetes have foot disease [1, 9]. Australia was reported
to have the lowest national foot disease prevalence with
1.5% [9]; but this Australian estimate was based on two
studies whose data are now more than 15 years old, one
of which only reported those with a history of DFD [10,
11]. Conversely, other reports published around the
same time suggested Australia had one of the highest
national diabetes-related amputation incidence rates
amongst developed nations; but these findings came
from non-peer reviewed government reports or narrative
reviews [12, 13].
These collective findings of low DFD prevalence and
high amputation incidence, suggests national health care
delivery in Australia for people at risk of DFD may be ef-
fective to prevent DFD, but may not be as effective to
prevent amputations in people that develop DFD. If
these interpretations are correct, this would suggest that
healthcare policymakers in Australia should focus more
on treatment for those with DFD to prevent amputation
and reduce high diabetes-amputation rates. Yet, these
findings come from different studies, in different popula-
tions, with different risk factors, at different time pe-
riods, using different outcome measures; this makes
interpretation challenging. Whilst one previous system-
atic review has reported on the epidemiology of chronic
wounds in Australia that included foot ulcers as a
wound type [14], no systematic review has comprehen-
sively synthesised the population-based findings of risk
factors for DFD, DFD and diabetes-related amputations.
Thus, we aimed to systematically review the prevalence
or incidence of risk factors for DFD (neuropathy, PAD,
previous ulcer, previous amputation, foot deformity), of
DFD (ulcers and infection), and of diabetes-related am-
putations (total, minor and major amputation) in
Australia populations.
Materials and methods
The systematic review was performed according to the
Preferred Reporting Items for Systematic Review and
Meta-Analyses (PRISMA) guidelines [15]. The review
was prospectively registered in the PROSPERO database
(CRD42016050740) and the protocol has been previously
published [16]. We summarise the methods used below.
Search strategy
The search included any original study published in any
language until 31 December 2019 in the PubMed and
EMBASE databases. These comprehensive databases
were chosen as they cover all peer-reviewed publications
back to 1951 (PubMed) and 1946 (EMBASE). We used
search strings combining MeSH terms and keywords for
prevalence or incidence, DFD or amputation, and
Australia. The search strings were finalised after ensur-
ing they identified a validation set of key publications
known to the authors and are shown in Table S1 of the
Supplementary material.
Eligibility assessment
The title and abstract of each publication identified from
the search were each screened by two investigators inde-
pendently for eligibility (JJvN, YZ or MB). To be eligible
for full-text assessment the publication had to report
epidemiological data on risk factors for DFD, on DFD or
on amputation in an Australian setting [16]. Any publi-
cation identified as eligible by at least one investigator
was retrieved for full-text assessment. Cohen’s kappa
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was calculated for screening agreement between
investigators.
Full-text assessments for each publication retrieved
were also performed by two investigators independently
for eligibility (YZ, JJvN, MB or QC) using the following
inclusion and exclusion criteria. The inclusion criteria
were that a publication needed to report an outcome of
interest in a population of interest. The outcomes of
interest for this review were risk factors for DFD (in-
cluding neuropathy, PAD, previous ulcer, previous am-
putation or foot deformity), DFD itself (defined as
“infection, ulceration, or destruction of tissues of the
foot of a person with currently or previous diagnosed
diabetes” [4]), and diabetes-related amputations (includ-
ing total, minor or major amputation(s)) as defined by
international guidelines [4, 16]. The populations of inter-
est for this review were populations from a defined geo-
graphical catchment area of Australia, including general
populations, community-dwelling populations with dia-
betes and inpatient populations. Any sub-groups of
interest from those populations were also included, such
as people with different types of diabetes (type 1 or 2
populations) and people of Aboriginal and Torres Strait
Islander ethnicity (hereafter respectfully referred to as
Indigenous populations). Exclusion criteria included
publications that did not report original data, the geo-
graphical catchment population of the centre(s) con-
cerned (unless data were standardised using Australian
population demographics), or outcomes of interest that
did not differentiate between people with and without
diabetes [16]. There were no restrictions on study dur-
ation, study period and publication date. Investigators
did not assess publications for which they were a (co-
)author to prevent potential bias or conflict of interest.
Disagreements in eligibility assessment between investi-
gators were resolved by discussion between those inves-
tigators until consensus was reached, or if consensus
was unable to be reached a third investigator decided.
All publications deemed fully eligible by both investiga-
tors were those included in this systematic review.
Quality assessment
Quality assessment of each included publication was also
performed by two investigators independently (YZ, JJvN,
MB, QC or PAL). Investigators did not assess publica-
tions for which they were a (co-)author to reduce poten-
tial bias or conflict of interest. A validated quality
assessment tool designed to assess the risk of bias in
population-based prevalence studies by Hoy and col-
leagues was used [17]. The tool assessed the quality of
nine key methodological aspects of prevalence studies,
including sample representation, random selection, ac-
ceptable case definitions, valid and reliable data collec-
tion instrument, and appropriate numerators and
denominators [17]. Aspects specific to the content of
this study included acceptable case definitions (if recom-
mended in international guidelines definitions [4]), and
valid and reliable data collection instrument (if the in-
strument or examination used had been previously re-
ported as being valid and/or reliable). All items were
afforded a score of one if reported and zero if not re-
ported or unsure. The only exception to this was for the
sample representation item, which scored two if the
population of interest was a close representation of the
national population, one if a close representation of a
provincial (“state”) population within Australia, or zero
if neither a national or state population (“regional”). The
total quality score for each outcome was calculated as
the sum of the nine assessment items, with the one item
having a possible score of two, rendering the highest
possible total score 10. The quality of the nine aspects
was assessed at an outcome level rather than at a publi-
cation level. Thus, publications that reported multiple
outcomes of interest had multiple total quality scores,
one for each outcome reported. All disagreements in
quality assessment between the two investigators were
resolved by discussion until consensus was reached, or if
consensus was unable to be reached a third investigator
decided.
Data extraction
Data were extracted into evidence tables from each in-
cluded publication by one investigator (YZ, MB, or
PAL), and then checked for accuracy by a second inves-
tigator (YZ, MB, or PAL). Investigators did not extract
or check data from which they were a (co-)author to re-
duce potential bias or conflict of interest. The data ex-
tracted included study setting, design, period, population
characteristics (including numbers, age, sex, diabetes
type, ethnic groups), outcomes of interest (including
method definitions used by the publication to identify
the outcome), use of prevalence or incidence, outcome
number, and proportion or rate. If the same original
findings were reported from the same study in two or
more publications, we used the findings from the earlier
publication. However, if additional numbers or findings
were reported we used the later publication. Disagree-
ments in data extraction between investigators were re-
solved by discussion until consensus was reached, or if
consensus was unable to be reached a third investigator
decided.
Data analysis
The summary measure used for each outcome of inter-
est in each included publication was proportion for
prevalence (%) or rate for incidence (per person-years).
If a publication only reported the outcome number, the
number was converted to a prevalence proportion, or
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crude incidence rate, by dividing the outcome of interest
number (numerator) by the population of interest num-
ber (denominator).
Eligibility criteria for performing a meta-analysis included
that there were at least three publications reporting on the
same outcome of interest, using similar definitions to identify
the outcome, in a similar population of interest, with data
collected within 10 years of each other. Meta-analyses would
be used to calculate pooled incidence or prevalence estimates
using a random-effects model, with the I2 test used to exam-
ine heterogeneity across publications.
No investigations of the effects of the risk of bias were per-
formed, including publication bias and selective reporting
within studies, as epidemiological studies rarely prospectively
register protocols and as such unpublished results to calcu-
late publication bias could not be estimated. Therefore, the
confidence in the cumulative evidence was a descriptive ana-
lysis based on the quality assessment of the included
publications.
Results
A total of 216 unique publications were identified from
the original search. After title and abstract screening,
181 publications were excluded with 35 remaining for
full-text assessment. Screening agreement between in-
vestigators was very high (Cohen’s kappa: 0.94). After
full-text assessment, 20 publications [10, 11, 18–35]
were included in this systematic review (see Fig. 1) with
15 excluded for not meeting inclusion criteria (see Table
S2). The eligibility criteria for performing any meta-
analysis was not met for any outcome of interest and
therefore only qualitative analyses of included publica-
tions are reported.
Data extraction
A summary of the characteristics of each of the 20 in-
cluded publications is provided in Table 1. The settings
reported included 15% (three of 20) that were nation-
wide [10, 20, 31]; 45% state-wide (including six from
Fig. 1 Preferred Reporting Items for Systematic Reviews and Meta-Analyses flow diagram
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Queensland (Qld), two from Western Australia
(WA) and one from Victoria (Vic)) [21, 23–29, 33];
and 40% were region-wide settings (including five
from Fremantle (WA) and one each from Far North
Qld (Qld), Darwin (Northern Territory (NT)) and
Central Australia) [11, 18, 19, 22, 30, 32, 34, 35].
The study designs included 35% that were prospect-
ive [11, 18, 19, 29, 32, 34, 35], 20% were cross-
sectional [10, 25–27], and the remaining 45% were
of retrospective design [20–24, 28, 30, 31, 33]. The
primary populations of interest investigated in-
cluded 25% that were a general population, 50% a
community-dwelling population with diabetes, and
25% an inpatient population. Subpopulations were
only reported amongst publications investigating
community-dwelling populations with diabetes and
included six publications reporting type 2 diabetes
and two each for type 1 diabetes and Indigenous
populations. The outcomes of interest reported in-
cluded eight publications reporting one or more
risk factors for DFD, five reporting DFD, eleven
reporting diabetes-related amputation, and four
reporting aggregated outcomes that included different
combinations of risk factors or DFD. Table 2 displays a
summary of the prevalence and incidence findings for the
outcomes of interest. Additionally, the evidence tables for
each outcome of interest are presented in the Supple-
mentary Material, including Table S3 for risk factors
of DFD, Table S4 for DFD, Table S5 for diabetes-
related amputations and Table S6 for aggregated risk
factors or DFD outcomes.
Quality assessments
Quality assessments were performed for 45 outcomes re-
ported across the 20 included publications as displayed
in Table 3. The median total quality score (IQR) was 7
(7-8) and scores ranged from 5 to 9 (from a total pos-
sible score of 10). Items recording higher risk of bias
scores included population of interest not representative
of a national population (89%, 40 of 45 outcomes; with
36% also not representative of a state population), out-
come of interest not measured using a valid or reliable
data collection instrument (60%), not collecting data
directly from participants (38%), having a non-response
bias (27%), and not using a random selection or census
method to identify the population of interest (24%).
Risk factors
Eight publications [10, 18, 21, 25, 27, 29, 32, 35] re-
ported the prevalence of different risk factors for DFD
and none reported incidence (Table 2; Table S3).
Peripheral neuropathy
Six publications [10, 18, 25, 29, 32, 35] reported neur-
opathy prevalence, with all using acceptable case defini-
tions and validated clinical examination methods for
measuring the outcome of neuropathy. This included
four publications investigating neuropathy within a
community-dwelling diabetes population, one in a
community-dwelling DFD population and one in an in-
patient population. In the community-dwelling diabetes
populations, neuropathy prevalence was 10.0% in a
nation-wide population, and 30.8–58.2% in region-wide






















































































aQA total scores listed correspond to, and are in the same sequence to, the outcomes reported in each publication. NS not stated; NT Northern Territory; PAD
peripheral artery disease; PN peripheral neuropathy; QA quality assessment; Qld Queensland; Vic Victoria; WA Western Australia
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Fremantle populations (including 38.9–48.5% in Indigen-
ous and 33.6–63.3% in non-Indigenous populations) [10,
18, 32, 35]. In a state-wide Qld community-dwelling
DFD population, neuropathy prevalence was 85.0% [29].
In a state-wide Qld inpatient population, diabetes-
related neuropathy prevalence was 10.2% (including
43.3% in diabetes inpatients) [25].
Peripheral artery disease (PAD)
Eight publications [10, 18, 21, 25, 27, 29, 32, 35] re-
ported PAD prevalence, with all using acceptable case
definitions and validated clinical examination methods
for measuring PAD, except one that used unvalidated
hospital coding methods. This included four investigat-
ing PAD in a community-dwelling diabetes population,
one a community-dwelling DFD population and three in
an inpatient population. In the community-dwelling dia-
betes populations, PAD prevalence was 10.3% in a
nation-wide population, 2.7% in state-wide Vic popula-
tion (hospital coding) [21], and 22.6–29.2% in region-
wide Fremantle population (including 15.8–30.7% in
Indigenous and 21.5–29.7% in non-Indigenous popula-
tions) [18, 32, 35]. In a state-wide Qld community-
dwelling DFD population, PAD prevalence was 45.8%
[29]. In a state-wide Qld inpatient population, diabetes-
related PAD prevalence was 8.2% (including 35.1% in
diabetes inpatients) [25, 27].
Previous foot ulcer
Four publications [10, 25, 29, 35] reported previous foot
ulcer prevalence, with all measured using acceptable case
definitions but unvalidated self-report methods, except
one that did not report an acceptable definition [10].
This included two investigating for those with previous
(healed) foot ulcers in a community-dwelling diabetes
population [10, 35], one in a community-dwelling DFD
population [29] and one in an inpatient population [25].
In the community-dwelling diabetes populations, previ-
ous foot ulcer prevalence was 2.1% in a nation-wide
population [10], and 0.5–1.8% in region-wide Fremantle
(WA) populations [35]. In a state-wide Qld community-
dwelling DFD population, previous foot ulcer prevalence
was 69.8% [29]. In a state-wide Qld inpatient population,
diabetes-related previous foot ulcer prevalence was 4.8%
(including 20.3% in diabetes inpatients) [25].
Previous amputation
Two publications [25, 29] reported previous amputation
prevalence, with both using an acceptable case definition
but unvalidated clinical examination method, including
one investigating those with previous (healed) amputa-
tions in a community-dwelling DFD population [29] and
one in an inpatient population [25]. In a state-wide Qld
community-dwelling DFD population, previous amputa-
tion prevalence was 28.4% [29]. In a state-wide Qld
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inpatient population, diabetes-related previous amputa-
tion prevalence was 2.2% (including 9.3% in diabetes in-
patients) [25].
Foot deformity
Two publications [25, 29] reported foot deformity preva-
lence, with both using an acceptable case definition but
unvalidated clinical examination methods, including one
investigating in a community-dwelling DFD population
and the other an inpatient population. In a state-wide
Qld community-dwelling DFD population, foot deform-
ity prevalence was 63.2% [29]. In a state-wide Qld in-
patient population, diabetes-related foot deformity
prevalence was 7.2% (including 30.5% in diabetes inpa-
tients) [25].
Diabetes-related foot disease (DFD)
Five publications [18, 19, 27, 29, 35] reported the out-




Three publications [18, 27, 35] reported foot ulcer
prevalence, with only one [27] using an acceptable case
definition and validated clinical examination method.
Two were investigating foot ulcers in a community-
dwelling diabetes population and one in an inpatient
population. In the community-dwelling diabetes popula-
tions, foot ulcer prevalence was 1.2–1.5% in the region-
wide Fremantle population [18, 35]. In a state-wide Qld
inpatient population, diabetes-related foot ulcer preva-
lence was 3.5% (including 15.1% in diabetes inpatients)
[27].
Incidence
One publication [18] reported foot ulcer hospitalisation
incidence using an acceptable case definition but unval-
idated hospital coding method (Table S4). The publica-
tion reported an incidence of 5.2 per 1000 person-years




One publication [27] reported foot infection prevalence,
using an acceptable case definition and validated clinical
examination method in an inpatient population. In a
state-wide Qld inpatient population, diabetes-related
foot infection prevalence was 1.7% (including 7.0% in
diabetes inpatients) [27].
Incidence
Two publications [19, 29] reported foot infection inci-
dence, with both using an acceptable case definition and
validated clinical examination method, including one in
a general population and one in a community-dwelling
DFD population (Table S4). In a region-wide Darwin
general population, the foot infection hospitalisation in-
cidence was 79 per 100,000 person-years (including 195
per 100,000 in Indigenous and 38 per 100,000 all
person-years in non-Indigenous populations) [19]. In a
state-wide Qld community-dwelling population, 40.1%
of people with non-infected diabetes-related foot ulcers
developed an infection over a 12 month period [29].
Diabetes-related amputation
Eleven publications [11, 19–24, 26, 28, 31, 33] reported
the outcomes of prevalence or incidence of diabetes-
related amputations (Table 2; Table S5).
Total amputations
Prevalence
Two publications [21, 26] reported total amputation
procedure prevalence, with only one using an acceptable
case definition and validated clinical examination
method [26]. In a state-wide Qld inpatient population,
diabetes-related amputation procedure prevalence was
1.4% (clinical methods) (including 5.8% in diabetes inpa-
tients) [26]. In a state-wide Vic inpatient population with
diabetes, amputation procedure prevalence was 1.4%
(hospital coding) [21].
Incidence
Six publications [11, 20, 24, 28, 31, 33] reported total
amputation procedure incidence, with all using an ac-
ceptable case definition and unvalidated hospital coding
method, except one using a validated clinical examin-
ation method [24]. This included two investigating am-
putations procedures in a general population [20, 31],
three in a community-dwelling diabetes population [11,
28, 33], and one reporting in both populations [24]. In
the general populations, diabetes-related total amputa-
tion incidence was 14.0–16.5 per 100,000 person-years
in nation-wide populations [20, 31], and 17.8 per 100,
000 in a state-wide Qld population [24]. In the
community-dwelling diabetes population, total amputa-
tion incidence was 5.2–6.9 per 1000 person-years in a
state-wide Qld diabetes populations [24, 33], 5.6 (type 2)
and 7.2 (type 1) per 1000 in a state-wide WA diabetes
population [28], and 6.0 per 1000 (type 2) in a region-
wide Fremantle population (including 3.8 per 1000 for
first ever amputation procedure) [11].
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Minor amputations
Five publications [11, 19, 23, 24, 28] reported minor am-
putation procedure incidence, with all using an accept-
able case definition and unvalidated hospital coding
method [11, 23, 24, 28], except one using a validated
clinical examination method [19]. This included two in-
vestigating amputation procedures in a general popula-
tion [19, 23], two in a community-dwelling diabetes
population [11, 23, 28], and one reporting both [24]. In
the general populations, diabetes-related minor amputa-
tion incidence was 12.0 per 100,000 person-years in a
state-wide Qld population [24], 24.0 per 100,000 in a
region-wide Darwin population (clinical method) [19],
and 28.9 per 100,000 in a state-wide WA non-
Indigenous population (≥50 years of age) and 185.0 in an
Indigenous population (≥50 years of age) [23]. In the
community-dwelling diabetes populations, minor ampu-
tation incidence was 3.5 per 1000 person years in a
state-wide Qld diabetes population [24], and 3.9 (type 2)
and 4.8 (type 1) per 1000 in a state-wide WA diabetes
population [28], and 2.3 for first ever minor amputation
procedure per 1000 (type 2) in a region-wide Fremantle
diabetes population [11].
Major amputations
Six publications [11, 19, 22–24, 28] reported major am-
putation incidence, again with all using an acceptable
case definition and unvalidated hospital coding methods,
except one using a validated clinical examination
method [19]. This included three in a general population
[19, 22, 23], two in a community-dwelling diabetes
population [11, 23, 28], and one reporting both [24]. In
the general populations, diabetes-related major amputa-
tion incidence was 5.8 per 100,000 person-years in a
state-wide Qld population [24], 7.6 per 100,000 region-
wide NT (Darwin) population (clinical method) [19], 9.3
per 100,000 in region-wide Far North Qld population
[22], and 13.1 (> 50 years non-Indigenous) and 76.8 (>
50 years Indigenous) per 100,000 in state-wide WA
population [23]. In the community-dwelling diabetes
populations, major amputation incidence was 1.7 per
1000 person-years in a state-wide Qld diabetes popula-
tion [24], 1.8 and 2.4 per 1000 (type 2 and 1 respectively)
in a state-wide WA diabetes population [28], and 1.8 for
first ever major amputation procedure per 1000 (type 2)
in a region-wide Fremantle diabetes population [11].
Aggregated risk factors or DFD outcomes
Four publications [24, 25, 27, 30] also reported the
prevalence or incidence of aggregated outcomes that in-
cluded different combinations of risk factors or DFD
outcomes (Table S6). All used acceptable case defini-
tions for the aggregated outcomes but unvalidated
clinical examination or hospital coding methods. This
included one in a general population [30], one in a
community-dwelling diabetes population [24] and two in
an inpatient population [25, 27]. In the general popula-
tion, incidence of hospitalisation for an aggregated DFD-
related outcome (neuropathy, PAD, foot ulcer, foot in-
fection, and/or amputation) was 98–285 per 100,000
person years in a Central Australia general population
over 15 years of age during 1992–1997 [30]. In a state-
wide Qld community-dwelling population with diabetes,
incidence of hospitalisation for an aggregated DFD-
related outcome (neuropathy, PAD, foot ulcer, foot in-
fection, amputation) was 20.2–36.6 per 1000 person-
years during 2005–2010 [24]. In a state-wide Qld in-
patient population with diabetes, the prevalence of being
hospitalised for the primary reason of an aggregated
DFD-related outcome (neuropathy, PAD, foot deformity,
previous foot ulcers, previous amputation, foot ulcer, in-
fection, amputation) was 8.7% and the prevalence of hav-
ing at least one risk factor, DFD or amputation outcome
present (neuropathy, PAD, foot deformity, previous foot
ulcers, previous amputation) was 65.5% [25, 27].
Discussion
We systematically reviewed the prevalence and incidence
of risk factors for DFD, DFD itself and diabetes-related
amputations in Australia. We found 20 publications that
reported on 45 outcomes within geographically defined
populations of Australia. Within community-dwelling
populations with diabetes in Australia, the prevalence of
those with key risk factors ranged from 10.0–58.2%,
those with DFD from 1.2–1.5%, and the incidence of
diabetes-related amputation ranged from 5.2–7.2 per
1000 person-years. We also found the incidence of those
with diabetes hospitalised for DFD-related outcomes
ranged from 5.2–36.6 per 1000 person-years. Further-
more, within those hospitalised with diabetes, the preva-
lence of key risk factors ranged from 35.3–43.3%, DFD
from 7.0–15.1% and those having amputation proce-
dures during their hospitalisation from 1.4–5.8%. How-
ever, there was a high level of heterogeneity between
studies for the populations investigated and the quality
of methods used to measure outcomes.
Our synthesised findings suggest that within people
with diabetes in Australia there is a relatively high pro-
portion that have risk factors for developing DFD, while
only a low proportion develop DFD, and a high propor-
tion of these appear to be hospitalised for DFD or
undergo amputations. However, the quantity and quality
of findings varied between outcomes. We found many
more publications reported on risk factors (eight publi-
cations) or diabetes-related amputations outcomes
(eleven), than on DFD itself (five). Furthermore, most
publications reporting risk factors or amputations used
acceptable methods to measure outcomes within a broad
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range of different populations; whereas, most publica-
tions reporting DFD did not use acceptable methods of
measurement and most were limited to within regional
populations. Therefore, we are more confident that our
synthesised findings indicating a high prevalence of risk
factors and high incidence of diabetes-related amputa-
tions are an accurate reflection of the burden of the
Australian population, than we are of a low prevalence
of DFD in Australia. With those caveats in mind, it is
useful to compare our synthesised Australian findings to
similar global findings to help interpret the national
burden and health care quality of DFD in Australia.
Risk factors
For key risk factors in community-dwelling populations
with diabetes, our Australian findings were somewhat
similar to those from global reviews [1, 36–39]. The 10–
58% range for neuropathy prevalence compared closely
with a 10–50% range [37] and a 34% pooled global
prevalence estimate [1] reported in two recent global re-
views. The 10–29% PAD prevalence range, and 35% in-
patient prevalence, also compared closely with a 20–29%
range identified in a global review of diabetes popula-
tions > 40 years [36], and with a 29–36% range in inpa-
tients [38, 39]. This suggests the national burden of key
risk factors for DFD, and perhaps the quality of care for
people with diabetes to prevent key risk factors for DFD
in Australia, is on par with other countries where data
are available.
Interestingly, we found no marked differences between
Indigenous and non-Indigenous people for these risk
factors, in contrast to a previous systematic review [40].
This may be explained by our tighter inclusion criteria
that included only population-based publications and in
turn only identified studies from urban settings [32],
while the previous review predominantly identified sin-
gle site clinic-based studies from remote settings [40],
with geographical remoteness known to increase DFD
rates [41].
Diabetes-related foot disease
In community-dwelling populations with diabetes, we
identified a DFU prevalence range of 1.2–1.5%. In 2020,
this would equate to ~ 16,400–20,500 Australians having
DFD (based on 1.2–1.5% of the 1.37 million Australians
with diabetes) [18, 34]. These findings are much lower
than the two recent pooled global prevalence estimates
of 4.6 and 4.8% [1, 9], but similar to the 1.5% pooled
Australian estimate from the same global review [9].
Interestingly though, for inpatient populations with dia-
betes, we identified a DFD prevalence range of 7.0–
15.1% [26, 27] which was much higher than a recent
pooled global prevalence estimate of 7.1% [9]. This sug-
gests that preventing DFD in Australia may be more
effective than in other countries, but care for those de-
veloping DFD may be less effective.
These interpretations are supported by our aggregated
DFD-related hospitalisation incidence findings. We
found 5.2–36.6 per 1000 person-years with diabetes,
which would equate to ~ 7100–50,000 DFD-related hos-
pitalisations each year in Australia [42]. Based on our
earlier estimates that ~ 16,400–20,500 Australians have
DFD, this would suggest there are ~ 0.3–3.1 hospitalisa-
tions for each Australian with DFD each year. However,
as identified earlier, we are less confident of the accuracy
of our low DFD prevalence findings. This lack of confi-
dence is perhaps emphasised by a recently reported ad-
justed estimate that ~ 45,000 Australians have DFD [1].
This estimate would equate to a ~ 3.2% DFD prevalence
in Australia which is much higher than the 1.2–1.5%
prevalence finding from this review [1]. This recent ad-
justed estimate was based on a validated Bayesian meta-
regression model that used similar Australian literature
to our review, but also adjusted for multiple known fac-
tors that influence DFD prevalence such as national
obesity prevalence and income per capita, and is there-
fore perhaps a more realistic estimate of the Australian
DFD prevalence [1].
Overall, these collective DFD findings suggest that per-
haps the DFD prevalence findings in our review are a
considerable under-estimate of the reality of the Austra-
lian national DFD burden [1]. Thus, large epidemiology
studies investigating DFD using validated methods in na-
tionally representative populations are needed to shed
more light on the reality of the national DFD burden.
Yet, with more confidence in our estimates that ~ 7100–
50,000 DFD-related hospitalisations are occurring each
year in Australia, urgent improvements are needed in
the understanding and delivery of national treatment
services for people with DFD to reduce such a large
national hospitalisation burden.
Diabetes-related amputation
We also found a comparatively high 5.2–7.2 total ampu-
tation incidence range per 1000 person-years with dia-
betes in Australia, compared with the 1.4–7.0 range
reported in a recent global systematic review [43]. Simi-
larly, we found what appears to be a very high 14.0–17.8
total amputation incidence range per 100,000 person-
years in the general population, compared with a recent
median rate over time of 9.4–9.9 reported for 26
Organization for Economic Cooperation and Develop-
ment (OECD) nations [44]. Whilst, the OECD median
rate excluded toe amputation procedures and those < 15
years of age, when interpreted with the diabetes popula-
tion findings these Australian total diabetes-related
amputation rates still seem comparatively high.
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For a more comprehensive interpretation of amputa-
tion, major and minor amputation rates should be teased
out [7, 45]. Whilst major amputations are a devastating
final resort treatment often performed to preserve life in
those with severe DFD, minor amputations can be con-
sidered to preserve the limb in those with moderate-to-
severe DFD, and have much different effects on quality
of life [7, 45]. We found a 1.7–2.4 major amputation in-
cidence range per 1000 person-years with diabetes in
Australia, and well within the range of 0.3–3.8 reported
in the recent global systematic review [43]. However, the
3.5–4.8 range for minor amputations was much higher
than the 0.9–3.6 reported in the global review [43]. This
again seems to support our earlier interpretation that
national treatment delivery in the community for people
with DFD may not be effective in preventing hospitalisa-
tion, resulting in more people hospitalised for DFD
receiving more minor amputation than in other nations.
We also found differences in amputation rates within
different sub-populations of Australia. Interestingly, we
found up to 38 fold higher rates for amputations in In-
digenous populations compared to the non-Indigenous
population [23], and much higher than the 3–6 fold
higher rates for amputations in Indigenous populations
reported in the previously discussed systematic review
[40]. Perhaps implicated in this finding, was that we
also found geographical variation in amputation rates
in two nation-wide publications [20, 31]. These studies
found higher diabetes-related amputation rates in the
most geographically remote state/territory of the
Northern Territory than all other states [20, 31]. Fur-
thermore, two statewide studies found significant de-
creases in diabetes-related amputation rates over time
following improved statewide health care delivery for
people with DFD [24, 28]. These collective findings
again point to higher amputation rates in those (sub-
)populations with lower access to DFD treatment, but
these rates may be reducible when access to DFD
health care treatment is improved in Australia. Lastly,
we found those with type 1 diabetes had slightly higher
rates than those with type 2 diabetes (7.2 total amputa-
tions per 1000 person-years in type 1 populations vs.
5.6–6.0 per 1000 in type 2) [11, 28]. However, like the
few previous studies in this area, this may be a descrip-
tive rather than a statistical difference, or perhaps those
with type 1 diabetes have a slightly more aggressive
DFD pathophysiology; regardless further investigation
is warranted [43].
Strengths and limitations
The findings of this review should be interpreted cogni-
sant of several limitations. First, although we searched
databases using a robust published search strategy [16],
we did not include grey literature and may have missed
some government reports in particular. However, grey
literature is rarely peer-reviewed and is difficult to iden-
tify with a reproducible search strategy, which risks
compromising the robustness of this review. Second, we
replaced the unvalidated quality assessment tool nomi-
nated in our published protocol [16] with a more appro-
priate validated quality assessment tool [17]. Last, the
high heterogeneity of included publications identified
prevented the pooling of outcomes using meta-analyses,
and thus, this review is reliant on descriptive findings
from rather diverse studies.
Conversely, a number of strengths should also be con-
sidered. First, it is the first review to comprehensively in-
terrogate the literature for a range of DFD-related
outcomes in Australia and provides the best evidence to
date on the burden of DFD in Australia. Second, this re-
view in the main adhered to published protocols, and
where there was variation it was to improve the robust-
ness of the published methodology. Third, we tested our
search strategy using a validation set and used independ-
ent investigators to assess the eligibility of all records
with very high agreement. Last, we used independent in-
vestigators who used a validated quality assessment tool
developed for the purpose of assessing such epidemi-
ology studies to quality assess all included papers.
With these strengths and limitations in mind, we rec-
ommend future robust epidemiology studies are urgently
needed to confirm or refute the interpretations made
from the heterogenous findings of this review. We
strongly suggest such studies apply international vali-
dated standards for measuring DFD-related outcomes
definitions within a nationally-representative population
to better inform the national burden of DFD in Australia
[4, 46]. However, until future robust studies return find-
ings, the best available evidence suggests that Australia
has a similar risk factor burden, an uncertain but per-
haps low community DFD burden, but a high DFD-
related hospitalisation and amputation burden compared
to the rest of the world. We recommend clinicians,
researchers and policymakers urgently investigate the
national healthcare treatment of people with DFD to try
and reduce what seems to be a very large burden of
disease caused by the hospitalisation and amputation of
Australians with DFD.
Conclusion
Our review has identified comparably similar prevalence
of risk factors, perhaps a low but uncertain prevalence of
DFD, but high incidence of DFD-related hospitalisation
and amputation in Australian populations. These find-
ings may suggest that a low proportion of people with
risk factors develop DFD, however, it is also possible that
there is an underestimation of DFD prevalence in
Australia in the few limited studies, given the high
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incidence of hospitalisation and amputation because of
DFD. Furthermore, we found these high amputation
rates were higher again in Indigenous and geographically
remote populations with lower access to DFD treatment.
We also found high heterogeneity between studies due
to the use of different definitions for DFD outcomes, dif-
ferent epidemiology metrics and populations reported.
Studies of nationally representative populations using
valid outcome measures for DFD are needed to verify
these findings.
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